AGP Executive Report
Last update: 2 hours agoAI Oversight: UK’s AI-in-healthcare regulator push calls for staged approvals and continuous real-world monitoring of medical AI systems. Cardio-Metabolic Link: A new review warns fatty liver disease may raise heart and kidney risk and premature death, urging it be treated as part of a broader organ-risk picture. New Treatments: Genentech’s Enspryng (satralizumab) gets U.S. FDA Priority Review for MOGAD, with a decision expected by Jan. 2027; Teitur Trophics reports Phase I success for its Parkinson’s peptide TT-P34 and plans Phase II in 2027. Hospital Safety & Accountability: Maharashtra orders action after an Amravati hospital fire killed three newborns, citing equipment and sprinkler/alarm failures. Maternal Care Expansion: Kenya’s Bumula Sub-County Hospital opens a 100-bed Mother and Child unit with incubators and X-ray services. Workforce Pressure: Manitoba adds doctors but still faces retention concerns after record net gains. Care Access & Costs: Ireland’s health professionals oppose raising the citizenship residence requirement, warning it could destabilize staffing. Patient Safety Lawsuit: Scotland’s children’s hospital morphine underdosing case heads to legal action over medication and safety-check failures. Community Health: A Post Falls hospital transitions from long-term acute care to inpatient rehab to meet local demand.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
